Neoadjuvant treatment patterns and biomarker selection in muscle-invasive bladder cancer

Neoadjuvant treatment patterns and biomarker selection in muscle-invasive bladder cancer

Abstract As the feasibility of risk-adaptive bladder-sparing treatment is increasingly validated, the prospects for neoadjuvant therapy in muscle-invasive bladder cancer (MIBC) are rapidly evolving. For patients seeking effective and tolerable treatment options, platinum-based chemotherapy, particul...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei He, Jiaxin Xie, Ziwei Wang, Maoyu Wang, Qing Chen, Chen Zhang, Yue Wang, Xufeng Yu, Yi Wang, Hui Zhang, Xuncheng Yang, Zhensheng Zhang, Chuanliang Xu, Shuxiong Zeng
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Oncology
Subjects:
Neoadjuvant therapy
Muscle-invasive bladder cancer
Clinical trials
Liquid biopsy
Online Access:https://doi.org/10.1007/s12672-025-02796-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-02796-6

Similar Items